Ironwood Pharmaceuticals | IRWD - Trade Debtors


Ironwood Pharmaceuticals reported $81.89M in Trade Debtors for its fiscal quarter ending in December of 2024.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.38M 153K Mar/2026
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Akebia Therapeutics USD 47.03M 19.19M Dec/2025
Almirall EUR 175.93M 17.87M Dec/2025
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
Amarin USD 126.83M 477K Dec/2025
Ardelyx USD 71.85M 4.76M Dec/2025
Astellas Pharma JPY 761.76B 48.47B Mar/2026
AstraZeneca USD 17.88B 1.17B Mar/2026
Charles River Laboratories USD 700.25M 727.92M Mar/2026
Coherus Biosciences USD 18.42M 232.08M Dec/2025
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Halozyme Therapeutics USD 457.99M 16.72M Mar/2026
Incyte USD 1.05B 27.09M Mar/2026
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
Lexicon Pharmaceuticals USD 2.38M 50K Dec/2025
MacroGenics USD 13.37M 55.86M Dec/2025
Moderna USD 71M 113M Mar/2026
Myriad Genetics USD 115.3M 2.7M Dec/2025
Pacira USD 125.64M 1.57M Mar/2026
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Sarepta Therapeutics USD 547.91M 149.68M Mar/2026
Takeda JPY 876.35B 118.43B Mar/2026
Ultragenyx Pharmaceutical USD 60M 98M Mar/2026
Vanda Pharmaceuticals USD 47.1M 4.35M Dec/2024